Amphetamines clinical trials at UC Irvine
1 in progress, 0 open to eligible people
Sorry, not yet accepting patients
This study is a pragmatic clinical trial examining the comparative effectiveness of two stimulant medications (methylphenidate and amphetamine) in the treatment of ADHD in children and adolescents with autism. Using a sequential, multiple assignment randomization trial (SMART) design the study will not only assess these two medications but also the role of an increasingly popular class of ADHD medication, the alpha-2 agonists. Findings from this study will help improve clinicians' approach to medication selection and reduce the repeated trials of multiple medications that are current standard care.
Irvine, California and other locations
Our lead scientists for Amphetamines research studies include Peter Chung, MD.